coronavirus (Page)
https://www.swisstph.ch/en/topics/coronavirus
Centre for Child Health Care (BRCCH). Together with the University of Geneva, Swiss TPH conducted an open-label cluster randomised trial, the COPEP trial , to assess the efficacy, safety and acceptability [...] (FHNW) and other partners. The Swiss TPH Disease Modelling unit developed a new mathematical model – OpenCOVID – to compare multiple vaccine rollout scenarios with several phased relaxation strategies to [...] range of current and future interventions to tackle the SARS-CoV-2 pandemic in...
TB-Practecal (Page)
https://www.swisstph.ch/en/about/med/clinical-operations/tb-practecal
to demonstrate safety and efficacy of particular treatment combinations remains. TB-Practecal is an open-label phase II/III randomized control trial that evaluates the safety and efficacy of of 6-month treatment
Surveillance and Health Systems (Page)
https://www.swisstph.ch/en/topics/malaria/surveillance-and-health-systems
The project focuses on monitoring and transparency of malaria treatment and costs through the use of openIMIS software in selected health districts. The software provides transparent information on treatment
Swiss TPH Symposium on Clinical Decision Support Systems (Page)
https://www.swisstph.ch/en/news/swiss-tph-symposium-on-clinical-decision-support-systems
d design, community engagement, use of CDSS data and collaboration for sustainability. After an opening address by Kaspar Wyss, Head of the Swiss Centre for International Health at Swiss TPH, Fenella Beynon
Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults... (Publications)
suppression in a rural, high-prevalence setting in sub-Saharan Africa. Design, Setting, and Participants: Open-label, 2-group, randomized clinical trial (February 22, 2016-September 17, 2017), involving 6 health
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis (Publications)
serious threat to public health in the WHO European region. Our regional and cross-country analyses open the door for strategies that can be tailored to leading pathogen-drug combinations and the available
Migration and Health for People on the Move | Swiss TPH Short Courses (Page)
https://www.swisstph.ch/en/study-with-us/postgraduate/migrationandhealth
expertise relating to child health, sexual and reproductive health, and mental health. The course is open to all interested participants involved in the field of migration health – locally, nationally and
SYSTAC (Page)
https://www.swisstph.ch/en/topics/systems-and-policies/systems-thinking-for-health/systaceuropeanhub
hub for Europe-based systems thinkers who are working inside Europe or in LMICs. The European hub is open to systems thinkers in research, policy, and practice. Our focal areas include: Health systems resilience
The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis (Publications)
serious threat to public health in the WHO European region. Our regional and cross-country analyses open the door for strategies that can be tailored to leading pathogen-drug combinations and the available
Effect of offering same-day ART vs usual health facility referral during home-based HIV testing on linkage to care and viral suppression among adults... (Publications)
suppression in a rural, high-prevalence setting in sub-Saharan Africa. Design, Setting, and Participants: Open-label, 2-group, randomized clinical trial (February 22, 2016-September 17, 2017), involving 6 health
